50
Participants
Start Date
June 30, 2020
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2027
PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC
"Patients enrolling on the protocol will undergo prostate-specific membrane antigen (PSMA) Positron Emission Tomography (PET)/Magnetic Resonance(MR) prior to start of the radiation treatment planning process. PSMA tracer is administered by IV injection and PET images are acquired.~Any patients found to have possible metastatic disease will undergo a standard of care confirmatory biopsy (if feasible) and receive treatment appropriate for their stage.~The PSMA PET/MR scan will be performed prior to initiation of androgen deprivation therapy (ADT)."
Stereotactic Body Radiation Therapy (SBRT)
Patients will receive standard of care radiation therapy (SBRT)
RECRUITING
Weill Cornell Medicine, New York
National Cancer Institute (NCI)
NIH
Weill Medical College of Cornell University
OTHER